ENHERTU (Trastuzumab Deruxtecan)

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of:

• adult patients with unresectable or metastatic HER2-positive breast cancer
• adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC) 
• adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma

• Monitor complete blood counts prior to initiation of enhertu 100 mg and prior to every dose, and as clinically indicated. 
• Assess LVEF before initiating therapy with trastuzumab deruxtecan 100 mg and at regular intervals while on therapy as clinically indicated. 
• Enhertu can cause fetal harm if used in pregnant women. Females of reproductive age should use effective contraception during treatment with enhertu 100 mg and for at least 7 months after the last dose.
• Due to the risk for serious adverse reactions in a breastfed child, advise women not to breastfeed during therapy with enhertu injection and for 7 months after the last dose.

What documents are required to import ENHERTU to India?

ENHERTU (fam-trastuzumab deruxtecan-nxki) can be imported by patients or government hospitals on behalf of patients.

The following documentation is required to import the product:

• Valid prescription from a qualified doctor.
• Patient’s diagnostic reports.
• Patient’s ID proof (issued by the Government of India).

How is the order confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription from a doctor.
• Import permit if applicable.

Is ENHERTU available in India?

ENHERTU is a prescription pharmaceutical drug that legally requires a medical prescription to be dispensed. Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input on:

• Availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.).
• Medicine Price.
• Finding genuine and reliable sources from Canada, Europe, USA, and Australia.
• Ensuring 100% transparency.

ENHERTU can be made available in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, and other cities in India.

Urgent Meds can facilitate the supply of ENHERTU (prescription medicines) to all locations in the world and in India after fulfilling the legal requirements (if applicable).

Please contact or mail at info@urgentmeds.in or call +1-647-818-4196 for ENHERTU price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is able to source the Enhertu Injection (Cancer Treatment Medicines) from across the globe and has the ability to supply. Urgent Meds offers its customers worldwide access to the best available treatment.

Urgent Meds is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address only from New Delhi, India.

Urgent Meds helps to connect patients with potential distributors, wholesalers, suppliers, and dealers of Enhertu in India.

What is the Generic Name for the trade name drug Enhertu®?

Trastuzumab Deruxtecan is the Generic Name for the trade name drug Enhertu®.

What is the Manufacturer’s Name of Enhertu®?

Enhertu® is manufactured by Daiichi Sankyo, Inc. and AstraZeneca.

Is Enhertu® approved by the FDA?

Yes, Enhertu® is approved by the FDA.

What is the price of Enhertu® in India?

To know the Enhertu® price in India, you can call or WhatsApp +1-647-818-4196 or email info@urgentmeds.in.

What is the dosage and form of Enhertu® available?

Enhertu® is available for Injection: 100 mg lyophilized powder in a single-dose vial.